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Abstract The present study is concerned with the development and 
characterization of bioadhesive carageenan gel encapsulating Amphotericin 
B and Lactobacillus acidophillus, prepared by graft co-polymeriztion against 
Candidal vaginitis. Intravaginal gel systems based on bioadhesive polymer 
(carrageenan) were characterized with respect to swelling index, bioadhesive 
strength, percent encapsulation and in vitro drug release antimicrobial studies. A 
marked increase in swelling index of gel encapsulating Lactobacillus was found 
to be 1.9±0.35. The percent encapsulation of drug was found to be 98.63%±.0.2% 
and that of Lactobacillus was 91.81 ±0.01. The viability was observed for interval 
of 6 hrs on trypton soya agar and showed that viability was highly conserved 
till 4 hrs. The antimicrobial study of gels encapsulating Amphotericin B and 
Lactobacillus showed that carageenan gel can inhibit Candida albicans upto 
a maximum extent. Bioadhesivity study also conducted for gels that showed a 
bioadhesivity of 84.66% ±.0.5% with drug, 88.66% ±.02% with Lactobacillus.
In-vitro drug release showed a sustained type release of drug from the polymer 
i.e. there was initial burst of Amphotericin B up to 5 hours, after which there was a
sustained release upto 10 days. Thus it has been concluded from the present
study that bioadhesive gels encapsulating Amphotericin B can act as promising
drug carriers along with Lactobacillus against candidal vaginitis.








Candidal Vaginitis (candidiasis) is a typical problem caused by Candida
albicans which is characterized by inflammation of the female genitalia. 
Vaginitis is very common and is reported by as many as 75% of women at some 
point in their lives. It is one of the most common forms of Candida infection in 
women. These fungi can be found all over the body and are normally present 
in moist areas of body. Donati and Di Vico (2010) has reported that 20%-
50% of all women normally carry yeast in the vagina without the presence of 
symptoms [1].
The vaginal flora is the dynamic system mainly consisting of Lactobacillus
(Doderlein’s bacilli) which is the most prevalent organism in vaginal 
environment together with many other facultative and obligate aerobes and 
anaerobes (Cornebacteria and yeast). The Lactobacilli produce sufficient 
lactic acid to acidify vaginal secretions to a pH 3.5 - 4.5. An imbalance in 
the intestinal flora where good bacteria are killed due to excessive use of 
antibiotics, unhealthy lifestyles and a weak immune system usually cause 
over growth of yeast. Various drugs which are used to cure candidal vaginitis 
are Amphotericin B, Fluconazole, Nystatin, metronidazole, Itraconazole, 
clotrimazole etc. Traditionally solutions, suppositories, foams and tablets have 
been used as vaginal formulations. Amphotericin B is one of the effective 
drugs used against candidal vaginitis which is a macrocyclic polyene with 
antifungal activity. It is associated with ergosterol, forming a transmembrane 
channel that leads to monovalent ion leakage causing fungal death. The drugs 
has various side effects like irritation, diarrhoea, headache, hypersensitivity, 
low availability of drug, poor patient compliance, and systemic side effects 
due to higher total dose and high frequency of drug administration. Sustained 
release drug delivery systems offer a promising approach in overcoming 
these drawbacks The use of mucoadhesive polymers for development of gels 
may help in controlled release of bioactive agents. Hydrogels are hydrophilic 
polymer networks which have the capability to imbibe water or biological 
fluids. They can exhibit dramatic changes in their swelling behaviour, network 
structure, permeability and mechanical strength in response to change in pH or 
ionic strength of surrounding fluid or temperature Gupta (2012) [2]. Probiotics 
offer alternative anticandidal approach as they lower the pH and help in 
restoring the balance of microflora. Probiotics are living micro organisms 
that favourably influence the health of the host by improving the indigenous 
microflora. Boskey et al. (2001) has confirmed that Lactobacilli pl ay an 
important role in the inhibition of growth, adhesion and spread of pathogenic 
microbes and thus possess good antimicrobial properties [3]. The present study 










based hydrogels encapsulating amphotericin B and probiotics as effective drug 
delivery systems against Candidal vaginitis.
2. MATERIALS AND METHODS
Commercially available IP injection of “Amphotericin B” under the brand 
name of Fungitericin manufactured by Gufic biosciences limited,Kabilpore, 
Navsari, Gujarat state.(India) was used, Sporolac manufactured by Uni Sankyo 
Ltd. containing around 150 million spores of Lactobacillus sporogenes in 
1g sachet was used in the study, Carrageenan, tryptone soya agar, dialysis 
membrane manufactured by HiMedia was used in the study, Lyophilized 
culture of Candida albicans (MTCC-183) was procured from IMTECH, 
Chandigarh, India. All the reagents of standard grade were used in the study. 
2.1 Preparation of Carrageenan Based Vaginal Gel Hosseinzadeh (2010)[4]
1g of kappa-carrageenan was dispersed in 30ml of distilled water. The 
dispersion was mixed using a magnetic stirrer for 20 minutes and then placed 
in a water bath at 80 0C for 20 minutes. After dissolving ĸ- carrageenan, the 
initiator Ammonium per sulphate (0.01g in 5 ml of distilled water) and 
Methylene bis acrylamide (0.05g in 5 ml of distilled water) were 
simultaneously added. The mixture was again stirred on a magnetic stirrer for 
20 min. The monomer acrylamide (1.0g) was added and gelation was observed 
after 15 min.1 ml of the drug Amphotericin B and 500mg spores of 
Lactobacillus was added to the 10 ml of gel and mixed thoroughly (By graft 
co-polymerisation ). 
2.2 Physicochemical Characterization of Gels Encapsulating Amphotericin B 
and Lactobacillus
2.2.1 Determination of pH of vaginal gel 
1g of gel was dissolved in 30 ml of distilled water and the electrode was then 
dipped in to gel formulation and constant reading was noted. The measurements 
of pH of each formulation were repeated three times Ramadan (2008) [5].
2.2.2 Swelling Index Studies
Swelling index is the measure of intensity of the gelation of the gel. More the 
swelling index, tighter the gel is and vice-versa.1g of gel was taken on a filter 
paper and then placed in a beaker containing SVF for 6 hours. Samples were 
removed from beakers at different time intervals (30 min., 60 min, 180 min, 
360 min.) Samples were put in a dry place for some time after that these were 






Swelling Index was calculated using: 
Sw% = [(Wt – W0) / W0] X 100
Sw = Equilibrium percent swelling
Wt= weight of swollen gel after time‘t’
W0= original weight of gel at zero time.
Where, T = amount of total drug, C=drug present in supernatant
2.2.3 Determination of encapsulation efficiency of gel 
To 1g of each vaginal gel 10ml of methanol was added in a volumetric flask 
followed by continuous shaking for 10 minutes and then diluted to100 ml with 
phosphate buffer (pH=7.4and centrifuged. The supernatant was filtered. The 
absorbance of filtrate was taken at 416 nm5.
Percent Encapsulation Totalamount of drug-amountof drugpresent= ×100
Totaldrug
2.2.4 In vitro Drug Release Studies
The in vitro release of drug was evaluated in phosphate buffer. For this 
the cellophane membrane was equilibrated with simulated vaginal fluid 
(SVF) overnight. In vitro release studies of Amphotericin B loaded 
vaginal gels was carried out for 10 days at room temperature by 
suspending dialysis bag (prepared from cellophane membrane) containing 
drug loaded gel in phosphate buffer. After regular intervals of 1h, 2h, 3h, 4h, 
5h, 6h, 24hrs, 1day, 2days, up to 10 days, 1 ml of supernatant was taken out 
and replaced with same amount of freshly prepared phosphate buffer. The 
sample from supernatant was taken in a quartz cuvette and diluted with 3 ml 
of distilled water. Absorbance was taken at 416 nm and concentration of drug 
was calculated from standard curve. The same procedure was followed to 
carry out in vitro drug release studies for Lactobacillus. Absorbance was 
taken at 340 nm.
Viability of Lactobacillus from the drug released in vitro:
100µl of phosphate buffer in which vaginal gels (containing Amphotericin 
B, combination of Amphotericin B with Lactobacillus) were suspended was 
taken at regular interval of 1 hour, 2 hours upto 6 hours and spread on trypton 
soya agar plates. The plates were incubated at 370C for 24-48 hours.
Bioadhesivity testing by in vitro wash off method:
The mucoadhesive properties of vaginal gels were evaluated by 
modified method of Patel et al. (2013) [7]. A fresh excised piece of goat 
intestine mucosa (2.5cm x 2.5cm) was mounted on a glass slide. The gel 










weight was applied over it for 5 minutes. Then the prepared specimen was 
transferred to the beaker placed at an angle of 600 from the surface beneath. 
The phosphate buffer from the burette at a constant flow rate of 2ml/min was 
added to the specimen .The test was carried out until the gel was removed 
from the mucosal surface.
For each of three vaginal gels, samples loaded with Amphotericin B, 
Lactobacillus alone, Amphotericin B and Lactobacillus in combination were 
developed to study the antimicrobial activity of the gels. Blank samples and 
free drug alone served as control. Supernatant of lactobacillus 100µl was 
added to well in a petriplates. The plates were incubated at 250C for 24 hours. 
The study was continued for 48 hours for the blank samples so as to check the 
biodegradability of the crosslinked gel.
RESULTS
In the current study we aimed at developing drug delivery systems based on 
natural polymer carageenan encapsulating Amphotericin B and Lactobacillus
against Candidal vaginitis. Bioadhesive gel systems were characterized based 
on pH, swelling index and percent encapsulation.
Physicochemical characterization of Carageenan gels encapsulating 
Amphotericin B and Lactobacillus
pH: pH of vaginal gels was estimated by mixing 1g of gel in 30 ml distilled 
water as optimized by Ramadan (2008)[5] with the help of pH meter [Table 1]: 
Table 1: pH of carageenan gels encapsulating Amphotericin B, Lactobacillus 
and their combinations.
S.No. Vaginal gels pH
(Mean + S.D)
1. Carageenan - Amphotericin B 7.2+ 0.10
2. Carageenan - Lactobacillus 6.75 + 0.005
3. Carrageenan - Amphotericin B + Lactobacillus 7.01 + 0.02
From above values it was seen value of pH increases in case of carageenan 






This is because of the effect of the Lactobacillus which is normal flora of 
vagina and tends to decrease the pH of the environment.
Percent Encapsulation of Carageenan Gel:
Amount of drug encapsulated in different gel systems was calculated as shown 
in Ramadan (2008) [5]. For this, to 1g of each vaginal gel 10ml of methanol 
was added in a volumetric flask followed by continuous shaking for 10 
minutes and then diluted to 100ml with phosphate buffer (pH=7.4)and 
centrifuged at 5000 rpm for 10 minutes. The supernatant was filtered. The 
absorbance of filtrate was taken at 416 nm as shown in [Table 2].
Table 2: Percent encapsulation of drug (Amphotericin B) and Lactobacillus.
S.No. Gels Encapsulation Efficiency
Mean ±S.D
1. Carageenan – Amphotericin B 98.63 ±0.23
2. Carageenan - Lactobacillus 91.81 ±0.01
Swelling Index:
Swelling index is the measure of intensity of the gelation of the gel. More 
the swelling index, tighter the gel is. As the swelling values of vaginal gels 
increases, the rate of drug release also increases [Figures 1, 2 and 3].











Viability of Lactobacillus in carageenan gels:
Viability of Lactobacillus was assayed in vaginal gels for 6 hours [Table 1]. 
100µl of phosphate buffer in which vaginal gels (containing both Amphotericin 
B and Lactobacillus) were suspended, was taken at regular interval of 1 hour, 
2 hours up to 6 hours and spread on trypton soya agar plates. The plates were 
incubated at 370C for 24-48 hours and examined.
The viability study of lactobacillus was even studied in vaginal gels as was 
done with gels encapsulating Carageenan gel. The viability was observed for 
interval of 6 hours on trypton soya agar. It was seen that viability conserved 
high viability till 4 hours but then it started decreasing.
Figure 4: In vitro drug release from carrageenan gel.







Bioadhesive strength of vaginal gels:
Bioadhesion implies the attachment of a drug carrier to a specified location 
study was done to see the adherence of drugs and lactobacillus to the epithelial 
cells of vagina. As the bioadhesivity increases, rate of drug release also 
increases as shown in [Table 4].











30 × 106 cfu/ml was given ‘-’, 30-150 × 106 cfu/ml was given ‘+’ and >150 × 106 cfu/ml 
was given ‘++’.
Table 4: Bioadhesive strength of carageenan gels.








In vitro drug release from carageenan gel:
The in vitro release of drug was evaluated in phosphate buffer. For this the 
cellophane membrane was equilibrated with simulated vaginal fluid (SVF) 
overnight. In vitro release studies of Amphotericin B loaded vaginal gels 
were carried out for 10 days at room temperature by suspending dialysis bag 
(prepared from cellophane membrane) containing drug loaded gel in phosphate 
buffer. The same procedure was followed for Lactobacillus.
Percentage of drug released up to 24 hrs from carrageenan gel = 12.55%











Percent of lactobacillus released upto 24 hrs from carageenan gel = 11.41%
Percent of lactobacillus released upto 10 days from carageenan gel = 78.42 %
DISCUSSION 
Candidal vaginitis is an infection of vagina which is characterized by 
inflammation of female genitalia. The causative agent is yeast Candida
albicans. Amphotericin B is one of the effective drugs used against candidal 
vaginitis. Probiotics is another strategy to use with the drugs against vaginitis 
as they lower the pH and helps in restoring the balance of microflora in vagina 
as demonstrated by Gil et al. (2010)  [8]. There are two modes of drug delivery 
for the treatment of candidal vaginitis-oral and vaginal. Presently marketed 
formulations include oral (tablets), suppositories, vaginal rings and creams. 
Vaginal drug delivery presents several advantages: ease of administration, 
hepatic first pass-effect bypass, low systemic drug exposure and increased 
permeability for some drugs when comparing to the oral or the other routes. 
Low enzymatic activity may also benefit drug delivery through vaginal route 
Merabet et al. (2005) [9]. In the current study intravaginal gel systems based 
on bioadhesive polymers like sodium alginate, chitosan, carrageenan were 
developed and characterized.
Several polymers including natural (collagen, carageenan, sodium alginate, 
chitosan, lectin etc.) and synthetic (lactic acid based polylactic-co-glycolic 
acid and polyanhydride, polyorthoesters, polycynoacylates, polycaprolactone) 
have been employed for formulating sustained release vaginal drug delivery 
system. Natural polymers e.g. carrageenan, chitosan and alginate have proved 
better over the synthetic polymers because of better bio compatibility, non 
toxicity and enhanced bioavailability.
In our present study natural polymers have been choosen for sustained drug 
delivery system against Candidal vaginitis. Carrageenan gel was prepared by 
graft co-polymerization of kappa-carrageenan, using ammonium per sulphate 
as a free radical initiator in the presence of methylene bisacrylamide as a cross 
linker. This hydro gel system exhibit a high sensitivity to pH and serves as 
a platform to a wide range of pharmaceuticals. Due to sensitivity for pH, it 
showed several changes of swelling and deswelling , which contributes to its 
suitability for controlled drug release.
The prepared bioadhesive gels showed pH near to the neutral pH, which 
indicates that none of the formulation will cause irritation in vaginal mucosa 
as reported by Sudeendra et al. (2010) [10].The surface pH of all formulations 






lactobacillus alone formulations shows the pH away from the neutral pH 
as seen in [Table 1]. Lactobacillus does not change the environment of 
the vagina, but it does interact with the environment to maintain normal 
conditions. Lactobacillus produce lactic acid, which help the vagina maintain 
a normal acidic pH. It works to try and prevent any other microbes from 
altering its pH by producing a balance of lactic acid to counter any intruding 
microbes. It has been reported in literature that Lactobacillus bacteria are 
also acidophilic (acid-loving), and therefore easily tolerate the acidic pH of 
the vagina. Their optimum pH range for growth is from pH=3.5 to pH=6.8.
Candida albicans grows well between pH=5.1 and 6.9. It is important to note 
that Candida albicans can survive a low, acidic pH environment (pH=2), but 
its growth is inhibited under such acidic conditions. Hence pH play important 
role in treatment of Candidal vaginitis.
Swelling index is the measure of intensity of the gelation of the gel. 
More the swelling index, tighter the gel is and vice-versa. As the swelling 
of polymer increase, drug release rate also increase. Our study depicts the 
difference between the swelling index of all vaginal gels encapsulating 
in carageenan, chitosan and sodium alginate polymers. It was seen from 
graphs that swelling index values increases with time and swelling index 
was more in case of carageenan and chitosan gels as compared to sodium 
alginate gels. According to the comparison of the corresponding swelling 
profiles of formulations with/without lactobacillus, i t c ould b e s een t hat 
the lactobacillus resulted in a marked increase in swelling rate. Increased 
value in swelling index means gel formed is tighter and hence will result in 
improved drug release. Dobaria et al. (2009) have reported that the swelling 
capability of polymer is crucial for its bio adhesiveness as adhesion occurs 
shortly after the swelling [11]. Swelling is important for the assessment of 
adhesion. After swelling, adhesion does occur, but with a weak bond formed. 
The phenomenon of swelling increasing can be explained by the good 
disintegration effect of Lactobacillus, which made gels increase in volume 
and construct porous channels on surface and inside of gels. The porous 
channels increased the area of contacting between polymer particles and 
water so that the polymers could be hydrated more easily.
Percent encapsulation was observed best with Amphotericin B as 
compared with Lactobacillus in the vaginal gels. It depends upon interaction 
and encapsulation of hydrophilic drug with hydrophobic polymer. [Table 2]
shows comparative percent encapsulation of Amphotericin B of carageenan, 
sodium alginate and chitosan gels are 98.63±0.23, 98.86±0.4 and 98.82±0.3 
respectively. It has been reported by Dhakar et al. (2012) that encapsulation 










Viability of lactobacillus was observed to check the adhesion of 
lactobacillus to vaginal epithelial cells. It was seen [Table 3] that viability of 
Lactobacillus was maximum till 4 hours and decreases at 6 hour. Lactobacillus 
viability was highly conserved till 4 hours but then it started decreasing with 
time. 
In vitro drug release studies were carried out in phosphate buffer under 
simulated vaginal conditions through a cellophane membrane. A faster release 
initially indicates that the drug in the solution in the space outside the gel 
matrix initially diffuses quickly. The release of drug within the gel is controlled 
by both the nature and concentration of polymer used. The bioadhesion in 
carrageenan may be due to the presence of more negative charges in the form 
of sulphate and carboxylic ions which help in attachment of gel to the mucus 
membrane more strongly as shown by Bhowmik and Nayak (2009) [13]. 
In our present study drug release kinetics of different vaginal gels 
showed a sustained type release of drug from the polymer i.e. there was 
initial burst of Amphotericin B up to 5 hours, after which there was a 
sustained release upto 10 days.
Bioadhesion is the formation of a bond by interfacial forces in which 
one surface is biological in nature. The bioadhesive strength of all vaginal 
gels [Table 4] results depict that vaginal gel formulation with both drug 
and Lactobacillus showed maximum strength. 
Amphotericin B and Lactobacillus encapsulated in carrageenan gel showed 
bioadhesive strength 84.66 ±0.5 and 88.66 ±0.2 respectively. Other workers 
explained that Bioadhesion is a very important aspect for maintaining high 
drug levels at the site of administration and prevents expulsion of 
formulation. By maintaining effective drug concentration for longer time, 
one can achieve successful eradication of infectious agent.
CONCLUSIONS
Carrageenan systems were found to have maximum bioadhesive 
properties that help in delaying vaginal transit of encapsulated compounds. 
The pH of vaginal gels was found to be less when the Lactobacillus was 
encapsulated in the carageenan gel. The percent encapsulation was best with 
the Amphotericin B drug of vaginal gels (carageenan-98.63 ±0.23). 
Bioadhesivity was observed best with Carageenan gels. The viability for 
Lactobacillus in the gel was high till for 4 hours. Antimicrobial studies of 
gels encapsulating Amphotericin B and Lactobacillus showed that 






compared to other two gels chitosan and sodium alginate. Thus it has been 
concluded from the present study that bioadhesive gels can act as promising 
therapeutic agents against candidal vaginitis.
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